bt02
Small moleculeexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 24, 2024 (NCT06404905)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07107204 | Phase 1/Phase 2 (Phase 2) | Oct 31, 2025 | Biotroy Therapeutics, China Academy of Chinese Medical Sciences |
| NCT07110363 | Phase 1 | Aug 31, 2025 | Biotroy Therapeutics |
| NCT07107178 | Phase 1 | Aug 8, 2025 | Biotroy Therapeutics, Peking University |
| NCT06404905 | Phase 1 | Jan 24, 2024 | Chinese Academy of Medical Sciences |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Biotroy Therapeutics | For profit | 3 | 3 | 2 | 2025 |
| China Academy of Chinese Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Peking University | Academic/Hospital | 1 | 0 | 1 | 2025 |
4 organizations
Page 1 / 1